Member Info for VistaMan

With the results due tomorrow I hope AA can update us on expected restart of production after the TAQA-operated P15-D maintenance is complete. Every days downtime at the current TTF price (60 Euro / MWH) is £720k lost revenue! Would also be good to hear if a portion of production has been hedged and at what level. AA has not been a fan of excessive hedging at RRE.
Vista

Suffolk,
Divide by 3.412 to get price in Euro/Mcf.
Vista

Bots, Why do you think the dividend to be announced in September will be less than the special dividend just received?

Urban, This comes up every so often on this board, I hold all my DEC shares in my Sipp and my wife's SIPP and pay 0% witholding tax on the dividends. In the past I also held some in an ISA and from what I remember paid 15% then. My broker is HL. If you have a significant holding it might be worth switching brokers if they can't be ar**d to fix it. 30% tax soon adds up!

ArbInv, The report was also hard for me to understand whether they had a good first half or a poor first half. The webinar for investors tonight helped a lot with my understanding particularly around the reported net loss of $84 MM. The main reason for this reported loss was the $371MM non-cash charge for unsettled financial instruments over the next 9.5 years due to rising strip prices. This charge doesn't affect cash flow in any way or the ability to pay dividends or debt repayment. In fact it creates an opportunity if sustained for DEC to raise their average hedged prices in the future as beyond 2022 a significant volume remains unhedged currently. Certainly went a long way to ally my concerns.

Insidious, You are either a complete and utter ramper like TH2 or have no idea how to value oil companies. You do realise that a 2p SP would give UKOG a £320MM market cap? Is that reasonable? I'll give you a quick external calibration - I3E, 18,000 boepd, paying a dividend, market cap £120MM. How stupid do you think people are to buy the garbage you post!

Hintza, The figure I used was 3412 cubic feet = 1 MWH. I took the NET to Kistos production in MMcf from the July production update and multiplied by E38.5 less OPEX costs of $5.50 per BOE and I get ~ £250k per day which is same ball park as extrapolation of Andrew's interview.
Vista

Hintza, I remembered the 60% share OK and will share detailed workings later today but possibly have used a wrong conversion figure in my calcs as never really worked in MWH units previously. An independent data point is the April 28 interview that Andrew gave where he quoted Kistos were earning in excess of £50 million EBITDA. That is equivalent to £137k per day. Dutch TTF gas prices in late April were ~E22.5 per MWH whereas currently they are E38.5 so EBITDA likely around £80-90 million per year or £240k per day.

Suffolk, Would you mind sharing how you get your daily cash figure? Have done some calculations myself and get a significantly higher figure that yours.
Vista.

Hello, have been steadily adding to my position here since listing. Has anyone seen any information on hedging for Kistos? I know Andrew wasn't a big fan of hedging when at RRE. A corporate presentation would be most welcome as weeding through the Admission document is very hard work. Has anyone had success in terms of contacting the company and getting a response?
Vista

Obviously demand from Retail was high.

Cuddles, One Accustem ADS per 1 TILS ADS. 1 Accustem ADS equals 2 Accustem shares.

Folks, First of all let me state that I agree the Acquisition Funding could have been handled much better, a fixed allocation for Primary Bid and an element of debt funding would have been desirable. But all is not lost, in many placing situations the share price falls to the placing price or below permitting purchase opportunities in the Open Market.
Funding issues aside I believe this is an attractive acquisition for both existing and new shareholders. The company is issuing 50% more shares and in return we get:
1. A 84% increase in Production
2. A 70% increase in Operating Income
3. A >150% increase in 2P reserves.
This should translate into an increased 2nd half dividend, albeit H1 likely reduced, but who knows, BOD might compensate for for the acquisition. :-)
Regarding Serenity farm-out, yes existing shareholders will have a lower share if a farm-out is successful but not sure it will have a great impact in the short term share price as any revenue from Serenity would be likely 2+ years ahead.

PL75 - "They’re hoping to wipe out enough in the summer so that the winter wave doesn’t overwhelm the NHS". On reflection is that your opinion? I am a LTH of AVCT and much as I regard our test, in itself its not enough to prevent waves of infection if for no other reason we don't have the capacity to do the level of testing that would require. So how would you like the government to move forward differently? By the way I never said you were anti-vax but was equating part of your post like their fake news.

PL75, I used to think you were a serious poster but that post is right up there with the usual anti-vaccinate fake news!

Share to Buy, Ever heard of statistics or Analysis Proportions? Why would 15% of the population be expected to have more deaths than 85% with the 15% typically being younger and healthier? Think before you post1

BB, Credit where its due to you. I certainly didn't foresee today's RNS for Home Treatment. Lets hope there is a good sound basis for the application.
Vista.

After today's update was happy to add another 110k shares. The potential for growth both organically and by acquisition at low multiples laid out for all to see in the presentation. The dividend policy of 30% FCF with a growing company is really a very attractive combination. Hard to find a more compelling investment on the market at the moment IMHO.

BB,
TILS are targetting treatment of COVID patients in hospital who have moved beyond the viral stage into the immune over-response stage. Its highly unlikely it would be an "at home" inhaled treatment for COVID. It could well be an at home treatment for some of the other targetted diseases however.
Vista

Not trying to put a dampener on things here but not sure why there would be a strong read across from the Regeneron news. Regeneron antibodies bind to the actual virus if I understand correctly whereas Foralumab works to "regulate" the immune system over-response.